Merchants of Meth: How Big Pharma Keeps the Cooks in Business
Pharma companies and big retailers “flooded our Capitol building with lobbyists from out of state,” he says. On the eve of the House vote, with the count too close to call, four legislators went out and bought 22 boxes of Sudafed and Tylenol Cold. They brought their loot back to the Legislature, where Bovett walked lawmakers through the process of turning the medicine into meth with a handful of household products. Without exceeding the legal sales limit, they had all the ingredients needed to make about 180 hits. The bill passed overwhelmingly.
Industry’s motto has been “stop meth, not meds.” One lawmaker likens it to the NRA’s “plea to people who own weapons that they are coming for your guns.”
Since the bill became law in 2006, the number of meth labs found in Oregon has fallen 96 percent. Children are no longer being pulled from homes with meth labs, and police officers have been freed up to pursue leads instead of cleaning up labs and chasing smurfers. In 2008, Oregon experienced the largest drop in violent-crime rates in the country. By 2009, property crime rates fell to their lowest in 43 years. That year, overall crime in Oregon reached a 40-year low. The state’s Criminal Justice Commission credited the pseudoephedrine prescription bill, along with declining meth use, as key factors.
For Big Pharma, however, Oregon’s measure was a major defeat—and the industry was not about to let it happen again. “They’ve learned from their mistakes in Oregon, they’ve learned from their mistakes in Mississippi,” says Marshall Fisher, who runs the Bureau of Narcotics in Mississippi. “They know if another state falls, and has the results that we’ve had, the chances of national legislation are that much closer. Every year they can fight this off is another year of those profits.”